Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI

Annals of Medicine

Volumn 32, Issue SUPPL. 1, 2000, Pages 68-72

  Hedner, U ^a   Erhardtsen, E ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

FVII FVIIa; Percutaneous transluminal coronary angioplasty; Recombinant FVIIa; Restenosis; Sepsis; TF FVII dependent haemostasis; Thrombus formation; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; FIBRIN; FIBRINOGEN; HEMOSTATIC AGENT; HEPARIN DERIVATIVE; PHOSPHOLIPID; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTHROPLASTY; BABOON; BLOOD CLOTTING; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CLINICAL TRIAL; COMPLEX FORMATION; CONFERENCE PAPER; DISEASE MODEL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; GRAFT PATENCY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RABBIT; REPERFUSION INJURY; RESTENOSIS; SEPSIS; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBUS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0034496733     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Initiation and regulation of tissue factor-dependent blood coagulation
2. The tissue factor pathway: How it has become a "prima ballerina"
3. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor
4. Blood-borne tissue factor: A new view of thrombosis
5. Platelet activity of high-dose factor VIIa is independent of tissue factor
6. Active site-inactivated Factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation
7. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
8. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets
9. The effect of active site-inhibited Factor VIIa on tissue factor-initiated coagulation using platelets before and after Aspirin administration
10. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity
11. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells
12. Incorporation of an active site inhibitor in Factor VIIa alters the affinity for tissue factor
13. Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists
14. The influence of blockade at specific levels of the coagulation cascade on restenosis in rabbit atherosclerotic femoral artery injury model
15. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis
16. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa
17. Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model
18. 100 Escherichia coli
19. Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid artery stenosis and myocardial infarction
20. Tissue factor inhibition reduces chronic vascular changes in rat aortic transplants
21. Efficacy and safety of FFR-rFVIIa in healthy volunteers
22. First clinical investigation of a tissue factor inhibitor administered during percutanaeous coronary revascularization: A randomised, double-blinded, dose-escalation trial
23. Tissue factor pathway inhibitor (TFPI) reduces mortality from Escherichia coli septic shock
24. Local application of tissue factor pathway inhibitor (TFPI) inhibits intimal hyperplasia induced by arterial interventions